Back to Journals » HIV/AIDS - Research and Palliative Care » Volume 12

First Report on HHV-6 Infection Among HIV-Infected Individuals Residing in Surabaya, Indonesia

Authors Oktafiani D, Megasari NLA, Ana EF, Nasronudin, Lusida MI, Soetjipto

Received 23 September 2019

Accepted for publication 3 February 2020

Published 17 March 2020 Volume 2020:12 Pages 107—112

DOI https://doi.org/10.2147/HIV.S232146

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Bassel Sawaya


Devi Oktafiani,1 Ni Luh Ayu Megasari,1,2 Elsa Fitri Ana,1 Nasronudin,1,3 Maria Inge Lusida,2,4 Soetjipto2,3,5

1Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; 2Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia; 3Universitas Airlangga Hospital, Surabaya, Indonesia; 4Department of Medical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; 5Department of Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

Correspondence: Soetjipto
Department of Medical Biochemistry, Faculty of Medicine, Universitas Airlangga, Mayjen Prof. Moestopo Street, No. 47, Surabaya 60131, Indonesia
Tel +62 81331340518
Email soetjipto1950@gmail.com

Background: Morbidity and mortality from acquired immunodeficiency syndrome (AIDS) are often associated with the reactivation of a herpes virus infection. Human herpesvirus-6 (HHV-6) is usually common in childhood infections that remain latent and can act as opportunists during immunosuppression to reactivate and cause disease. In human immunodeficiency virus (HIV)-infected patients, the impact of HHV-6 infection can be an up-regulator of HIV replication and accelerate progress towards AIDS. However, studies on HHV-6 infection have never been done in Surabaya, Indonesia.
Purpose: To determine the presence of HHV-6 infection among HIV-infected individuals residing in Surabaya, Indonesia.
Patients and Methods: Plasma and peripheral blood mononuclear cells (PBMCs) were collected from 85 HIV-infected individuals in Universitas Airlangga Hospital, Surabaya, as well as 85 healthy controls. DNA extracted from PBMCs was subjected to PCR to determine HHV-6 infection, while plasma of HIV-infected individuals was used for viral RNA quantification using real-time PCR.
Results: HHV-6 infection was detected in 17.6% (15/85) of HIV-infected individuals, and in 3.53% (3/85) of healthy controls. Thus, HHV-6 infection was more likely to be found in HIV-infected individuals than in healthy controls (odds ratio 5.85; 95% confidence interval, 1.6– 21). The HHV-6B was the most common subtype identified in both HIV-infected individuals (12/15) and healthy controls (3/3). The HHV-6A and co-infection between HHV-6A and HHV-6B were only found in HIV-infected individuals (2/15 and 1/15, respectively). Viral RNA load of HIV-infected individuals was not correlated to HHV-6 infection.
Conclusion: Our results indicate the emergence of HHV-6 infection among HIV-infected individuals residing in Surabaya, Indonesia, and the risk of HHV-6 infection was higher in HIV-infected individuals than in healthy controls.

Keywords: HHV-6, HIV-infected individuals, healthy controls, Surabaya, Indonesia

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]